| dc.date.accessioned | 2022-12-01T12:16:41Z | |
| dc.date.available | 2022-12-01T12:16:41Z | |
| dc.date.issued | 2021-12-03 | |
| dc.identifier.citation | Ireland. Health Information and Quality Authority, 'Duration of protective immunity following COVID-19 vaccination of individuals with underlying conditions (efficacy and effectiveness). Provided to NIAC: 4 November 2021', [report], Health Information and Quality Authority, 2021-12-03 | en |
| dc.language.iso | en | en |
| dc.publisher | Health Information and Quality Authority | en |
| dc.rights | Y | en |
| dc.subject | Covid-19 | en |
| dc.subject | Coronavirus | en |
| dc.subject | Vaccination | en |
| dc.subject | Immunity | en |
| dc.subject | Underlying conditions | en |
| dc.subject | National Immunisation Advisory Committee (NIAC) | en |
| dc.title | Duration of protective immunity following COVID-19 vaccination of individuals with underlying conditions (efficacy and effectiveness). Provided to NIAC: 4 November 2021 | en |
| dc.type | report | en |
| dc.type.supercollection | edepositireland | |
| dc.contributor.corporatename | Ireland. Health Information and Quality Authority | en |
| dc.publisher.place | IE | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.relation.relatedto | TCD Covid-19 Collection | |
| dc.identifier.uri | http://hdl.handle.net/2262/101785 | |
